Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Daiichi Sankyo selects DT-831j as clinical candidate for thrombosis

Aug. 22, 2007

Design and pharmacological characterization of ILS-920 presented at ACS meeting

Aug. 22, 2007

Wyeth continues to search for potent, orally active LXR agonists with good selectivity

Aug. 21, 2007

M2-selective development candidate for OAB presented by Theravance

Aug. 21, 2007

Potent, orally active lead LTB4 hydrolase inhibitor selected at J&J

Aug. 21, 2007

Boston-based investigators focus on the identification of necroptosis inhibitors

Aug. 21, 2007

Novel, potent hydroxyhydantoin MMP inhibitors presented at ACS meeting

Aug. 20, 2007

Hedgehog signaling activators discovered with potential in neurodegenerative disorders

Aug. 20, 2007

New recombinant neuregulin-1 ameliorates cardiac output in chronic heart failure

Aug. 20, 2007

New PI3K inhibitor described by Merck Serono

Aug. 16, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...